Compare AUTL & IIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | IIM |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.6M | 584.6M |
| IPO Year | 2018 | N/A |
| Metric | AUTL | IIM |
|---|---|---|
| Price | $1.65 | $12.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 122.2K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.63% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $51,128,000.00 | N/A |
| Revenue This Year | $658.11 | N/A |
| Revenue Next Year | $91.34 | N/A |
| P/E Ratio | ★ N/A | $591.50 |
| Revenue Growth | ★ 406.67 | N/A |
| 52 Week Low | $1.11 | $9.94 |
| 52 Week High | $2.80 | $12.32 |
| Indicator | AUTL | IIM |
|---|---|---|
| Relative Strength Index (RSI) | 60.25 | 36.16 |
| Support Level | $1.56 | $12.27 |
| Resistance Level | $1.69 | $12.36 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 89.92 | 2.63 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income that is exempt from federal income tax.